Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$52.24M
60 trades · 6 insiders
Net · 90d
$-52.24M
Insiders on file
18
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | 29 | $0 | $7.61M | 2026-09-17 |
| Randhawa Simrat | EVP, Head of R&D | 59 | $52.8K | $17.46M | 2026-09-01 |
| Read Simon | Director | 24 | $0 | $1.26M | 2026-08-19 |
| Veness Adam M | SVP, General Counsel and Sec. | 26 | $0 | $6.84M | 2026-08-13 |
| McGeorge Anne | Director | 22 | $0 | $1.69M | 2026-08-10 |
| Garcia Marino | CEO AND PRESIDENT, Director | 38 | $0 | $45.91M | 2026-08-07 |
| Savitz Ryan | EVP, CFO & CBO | 31 | $0 | $14.99M | 2026-07-09 |
| Violin Jonathan | Director | 4 | $0 | $0 | 2026-05-21 |
| Soteropoulos Paula | Director | 13 | $0 | $2.25M | 2026-05-21 |
| Romano Steven J. | Director | 3 | $0 | $0 | 2026-05-21 |
| Lawton Alison Frances | Director | 4 | $0 | $0 | 2026-05-21 |
| KANGO SUJAY | Director | 2 | $0 | $0 | 2026-05-21 |
| Kiselak Tomas | Director, 10% Owner | 8 | $1.06M | $0 | 2024-09-27 |
| Fairmount Funds Management LLC | Director, 10% Owner | 3 | $0 | $0 | 2024-05-23 |
| MOULDER LEON O JR | Director | 3 | $0 | $0 | 2024-05-23 |
| Avidity Partners Management (GP) LLC | Director | 2 | $0 | $0 | 2024-01-22 |
| Harwin Peter Evan | Director, 10% Owner | 1 | $336.3K | $0 | 2023-09-29 |
| Avidity Partners Management LP | Director | 1 | $0 | $0 | 2023-09-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 20,000 | — | $0 | 43,818 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 1,100 | $103.20 | $113.5K | 700 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 700 | $104.39 | $73.1K | 0 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 3,501 | $102.39 | $358.5K | 1,800 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 6,771 | $101.37 | $686.4K | 5,301 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 7,928 | $100.43 | $796.2K | 12,072 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 20,000 | $17.88 | $357.6K | 20,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 20,000 | — | $0 | 43,818 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 700 | $104.39 | $73.1K | 0 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 1,100 | $103.20 | $113.5K | 700 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 3,501 | $102.39 | $358.5K | 1,800 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 6,771 | $101.37 | $686.4K | 5,301 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 7,928 | $100.43 | $796.2K | 12,072 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 20,000 | $17.88 | $357.6K | 20,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 7,500 | — | $0 | 56,776 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,249 | — | $0 | 41,676 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,375 | — | $0 | 87,500 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 13,309 | $106.74 | $1.42M | 4,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 7,215 | $106.25 | $766.6K | 17,309 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 2,600 | $105.19 | $273.5K | 24,524 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 9,375 | $22.07 | $206.9K | 27,124 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 6,249 | $21.77 | $136.0K | 17,749 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 7,500 | $17.88 | $134.1K | 11,500 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,375 | — | $0 | 87,500 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,249 | — | $0 | 41,676 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 7,500 | — | $0 | 56,776 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 13,309 | $106.74 | $1.42M | 4,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 7,215 | $106.25 | $766.6K | 17,309 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-09-01 | 2026-09-03 | 2,600 | $105.19 | $273.5K | 24,524 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 9,375 | $22.07 | $206.9K | 27,124 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 6,249 | $21.77 | $136.0K | 17,749 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-09-01 | 2026-09-03 | 7,500 | $17.88 | $134.1K | 11,500 | SEC↗ |
| Read Simon | Director | M Exercise deriv | 2026-08-19 | 2026-08-19 | 2,778 | — | $0 | 19,445 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-19 | 2026-08-19 | 2,778 | $117.55 | $326.6K | 0 | SEC↗ |
| Read Simon | Director | M Exercise | 2026-08-19 | 2026-08-19 | 2,778 | $18.36 | $51.0K | 2,778 | SEC↗ |
| Read Simon | Director | M Exercise deriv | 2026-08-19 | 2026-08-19 | 2,778 | — | $0 | 19,445 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-19 | 2026-08-19 | 2,778 | $117.55 | $326.6K | 0 | SEC↗ |
| Read Simon | Director | M Exercise | 2026-08-19 | 2026-08-19 | 2,778 | $18.36 | $51.0K | 2,778 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-13 | 2026-08-14 | 15,000 | — | $0 | 73,240 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-13 | 2026-08-14 | 15,000 | $18.17 | $272.6K | 15,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-13 | 2026-08-14 | 15,000 | — | $0 | 73,240 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-13 | 2026-08-14 | 15,000 | $18.17 | $272.6K | 15,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-10 | 2026-08-11 | 16,167 | — | $0 | 60,000 | SEC↗ |
| Read Simon | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 2,777 | — | $0 | 22,223 | SEC↗ |
| McGeorge Anne | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 6,500 | — | $0 | 0 | SEC↗ |
| McGeorge Anne | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 1,250 | — | $0 | 0 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-10 | 2026-08-11 | 16,167 | $110.38 | $1.78M | 0 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-10 | 2026-08-11 | 16,167 | $17.88 | $289.1K | 16,167 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 470 | $111.05 | $52.2K | 397 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 397 | $111.77 | $44.4K | 0 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 272 | $109.96 | $29.9K | 867 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 831 | $108.95 | $90.5K | 1,139 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 737 | $108.17 | $79.7K | 1,970 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 70 | $107.11 | $7.5K | 2,707 | SEC↗ |
| Read Simon | Director | M Exercise | 2026-08-10 | 2026-08-11 | 2,777 | $18.36 | $51.0K | 2,777 | SEC↗ |
| McGeorge Anne | Director | M Exercise | 2026-08-10 | 2026-08-11 | 1,250 | $19.36 | $24.2K | 1,250 | SEC↗ |
| McGeorge Anne | Director | M Exercise | 2026-08-10 | 2026-08-11 | 6,500 | $11.20 | $72.8K | 7,750 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,450 | $107.58 | $156.0K | 6,300 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 2,800 | $108.38 | $303.5K | 3,500 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,800 | $109.30 | $196.7K | 1,700 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 700 | $111.41 | $78.0K | 0 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,000 | $110.64 | $110.6K | 700 | SEC↗ |
| McGeorge Anne | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 6,500 | — | $0 | 0 | SEC↗ |
| McGeorge Anne | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 1,250 | — | $0 | 0 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 700 | $111.41 | $78.0K | 0 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,000 | $110.64 | $110.6K | 700 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,800 | $109.30 | $196.7K | 1,700 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 2,800 | $108.38 | $303.5K | 3,500 | SEC↗ |
| McGeorge Anne | Director | S Sale | 2026-08-10 | 2026-08-11 | 1,450 | $107.58 | $156.0K | 6,300 | SEC↗ |
| McGeorge Anne | Director | M Exercise | 2026-08-10 | 2026-08-11 | 6,500 | $11.20 | $72.8K | 7,750 | SEC↗ |
| McGeorge Anne | Director | M Exercise | 2026-08-10 | 2026-08-11 | 1,250 | $19.36 | $24.2K | 1,250 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-10 | 2026-08-11 | 16,167 | — | $0 | 60,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-10 | 2026-08-11 | 16,167 | $110.38 | $1.78M | 0 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-10 | 2026-08-11 | 16,167 | $17.88 | $289.1K | 16,167 | SEC↗ |
| Read Simon | Director | M Exercise deriv | 2026-08-10 | 2026-08-11 | 2,777 | — | $0 | 22,223 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 397 | $111.77 | $44.4K | 0 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 470 | $111.05 | $52.2K | 397 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 272 | $109.96 | $29.9K | 867 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 831 | $108.95 | $90.5K | 1,139 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 737 | $108.17 | $79.7K | 1,970 | SEC↗ |
| Read Simon | Director | S Sale | 2026-08-10 | 2026-08-11 | 70 | $107.11 | $7.5K | 2,707 | SEC↗ |
| Read Simon | Director | M Exercise | 2026-08-10 | 2026-08-11 | 2,777 | $18.36 | $51.0K | 2,777 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise deriv | 2026-08-07 | 2026-08-07 | 126,000 | — | $0 | 160,004 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise deriv | 2026-08-07 | 2026-08-07 | 40,000 | — | $0 | 286,004 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-07 | 2026-08-11 | 3,833 | — | $0 | 76,167 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 21,909 | $108.72 | $2.38M | 65,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 10,384 | $107.49 | $1.12M | 220,908 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise | 2026-08-07 | 2026-08-07 | 126,000 | $8.44 | $1.06M | 231,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise | 2026-08-07 | 2026-08-07 | 40,000 | $8.44 | $337.6K | 105,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 23,907 | $108.05 | $2.58M | 197,001 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 104,091 | $107.96 | $11.24M | 87,102 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 800 | $110.76 | $88.6K | 191,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 2,536 | $110.02 | $279.0K | 192,092 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-08-07 | 2026-08-07 | 2,373 | $109.10 | $258.9K | 194,628 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-07 | 2026-08-11 | 3,833 | $17.88 | $68.5K | 3,833 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-07 | 2026-08-11 | 3,217 | $110.61 | $355.8K | 616 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-07 | 2026-08-11 | 616 | $111.18 | $68.5K | 0 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | M Exercise deriv | 2026-08-07 | 2026-08-07 | 126,000 | — | $0 | 160,004 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | M Exercise deriv | 2026-08-07 | 2026-08-07 | 40,000 | — | $0 | 286,004 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 21,909 | $108.72 | $2.38M | 65,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 104,091 | $107.96 | $11.24M | 87,102 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 800 | $110.76 | $88.6K | 191,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 2,536 | $110.02 | $279.0K | 192,092 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 2,373 | $109.10 | $258.9K | 194,628 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 23,907 | $108.05 | $2.58M | 197,001 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | S Sale | 2026-08-07 | 2026-08-07 | 10,384 | $107.49 | $1.12M | 220,908 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | M Exercise | 2026-08-07 | 2026-08-07 | 126,000 | $8.44 | $1.06M | 231,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT, Director | M Exercise | 2026-08-07 | 2026-08-07 | 40,000 | $8.44 | $337.6K | 105,292 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-08-07 | 2026-08-11 | 3,833 | — | $0 | 76,167 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-07 | 2026-08-11 | 616 | $111.18 | $68.5K | 0 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-08-07 | 2026-08-11 | 3,217 | $110.61 | $355.8K | 616 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-08-07 | 2026-08-11 | 3,833 | $17.88 | $68.5K | 3,833 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise deriv | 2026-07-09 | 2026-07-13 | 31,249 | — | $0 | 68,751 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-07-09 | 2026-07-13 | 15,329 | $101.24 | $1.55M | 5,566 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-07-09 | 2026-07-13 | 5,566 | $101.97 | $567.6K | 0 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-07-09 | 2026-07-13 | 10,354 | $100.22 | $1.04M | 20,895 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise | 2026-07-09 | 2026-07-13 | 31,249 | $21.77 | $680.3K | 31,249 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise deriv | 2026-06-17 | 2026-06-18 | 30,000 | — | $0 | 80,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-06-17 | 2026-06-18 | 16,771 | $80.34 | $1.35M | 13,229 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | M Exercise | 2026-06-17 | 2026-06-18 | 30,000 | $17.88 | $536.4K | 30,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | S Sale | 2026-06-17 | 2026-06-18 | 13,229 | $81.38 | $1.08M | 0 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-06-01 | 2026-06-02 | 6,249 | — | $0 | 47,925 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-06-01 | 2026-06-02 | 3,998 | — | $0 | 0 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-06-01 | 2026-06-02 | 6,908 | — | $0 | 64,276 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-06-01 | 2026-06-02 | 9,375 | — | $0 | 96,875 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-06-01 | 2026-06-02 | 3,998 | $8.44 | $33.7K | 7,998 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-06-01 | 2026-06-02 | 6,908 | $17.88 | $123.5K | 14,906 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-06-01 | 2026-06-02 | 6,249 | $21.77 | $136.0K | 21,155 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-06-01 | 2026-06-02 | 9,375 | $22.07 | $206.9K | 30,530 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-06-01 | 2026-06-02 | 5,428 | $89.72 | $487.0K | 25,102 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-06-01 | 2026-06-02 | 4,159 | $91.37 | $380.0K | 4,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-06-01 | 2026-06-02 | 16,943 | $90.72 | $1.54M | 8,159 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Romano Steven J. | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Soteropoulos Paula | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| KANGO SUJAY | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Read Simon | Director | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise deriv | 2026-05-08 | 2026-05-11 | 599 | — | $0 | 0 | SEC↗ |
| Soteropoulos Paula | Director | S Sale | 2026-05-08 | 2026-05-11 | 599 | $85.47 | $51.2K | 0 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise | 2026-05-08 | 2026-05-11 | 599 | $8.44 | $5.1K | 599 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise deriv | 2026-04-09 | 2026-04-10 | 8,224 | — | $0 | 71,776 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-04-09 | 2026-04-10 | 8,224 | $89.84 | $738.8K | 0 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise | 2026-04-09 | 2026-04-10 | 8,224 | $17.88 | $147.0K | 8,224 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise deriv | 2026-03-31 | 2026-04-01 | 599 | — | $0 | 599 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise deriv | 2026-03-31 | 2026-04-01 | 40,000 | — | $0 | 80,000 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise deriv | 2026-03-31 | 2026-04-01 | 74,367 | — | $0 | 10,399 | SEC↗ |
| Soteropoulos Paula | Director | S Sale | 2026-03-31 | 2026-04-01 | 599 | $80.11 | $48.0K | 0 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise | 2026-03-31 | 2026-04-01 | 599 | $8.44 | $5.1K | 599 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise | 2026-03-31 | 2026-04-01 | 74,367 | $8.44 | $627.7K | 74,367 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | M Exercise | 2026-03-31 | 2026-04-01 | 40,000 | $17.88 | $715.2K | 114,367 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 1,390 | $78.33 | $108.9K | 112,977 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 7,232 | $85.54 | $618.6K | 0 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 19,469 | $84.57 | $1.65M | 7,232 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 59,800 | $83.90 | $5.02M | 26,701 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 2,366 | $82.84 | $196.0K | 86,501 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 800 | $81.36 | $65.1K | 88,867 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 1,485 | $80.25 | $119.2K | 89,667 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | S Sale | 2026-03-31 | 2026-04-01 | 21,825 | $78.86 | $1.72M | 91,152 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise deriv | 2026-03-24 | 2026-03-26 | 27,594 | — | $0 | 1,198 | SEC↗ |
| Soteropoulos Paula | Director | M Exercise | 2026-03-24 | 2026-03-26 | 27,594 | $8.44 | $232.9K | 27,594 | SEC↗ |
| Soteropoulos Paula | Director | S Sale | 2026-03-24 | 2026-03-26 | 27,594 | $78.05 | $2.15M | 0 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise deriv | 2026-03-16 | 2026-03-17 | 5,592 | — | $0 | 269,408 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise deriv | 2026-03-16 | 2026-03-17 | 59,700 | — | $0 | 41 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise | 2026-03-16 | 2026-03-17 | 5,592 | $17.88 | $100.0K | 65,292 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise | 2026-03-16 | 2026-03-17 | 59,700 | $6.70 | $400.0K | 59,700 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-03-12 | 2026-03-13 | 5,000 | — | $0 | 71,184 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-03-12 | 2026-03-13 | 7,998 | — | $0 | 3,998 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-03-12 | 2026-03-13 | 12,500 | — | $0 | 106,250 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2026-03-12 | 2026-03-13 | 8,332 | — | $0 | 54,174 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-03-12 | 2026-03-13 | 17,500 | — | $0 | 42,500 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-03-12 | 2026-03-13 | 10,000 | — | $0 | 50,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-03-12 | 2026-03-13 | 16,182 | — | $0 | 63,818 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise deriv | 2026-03-12 | 2026-03-13 | 122,918 | — | $0 | 59,741 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2026-03-12 | 2026-03-13 | 33,830 | $81.48 | $2.76M | 0 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-03-12 | 2026-03-13 | 7,998 | $8.44 | $67.5K | 7,998 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-03-12 | 2026-03-13 | 5,000 | $17.88 | $89.4K | 12,998 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-03-12 | 2026-03-13 | 8,332 | $21.77 | $181.4K | 21,330 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2026-03-12 | 2026-03-13 | 12,500 | $22.07 | $275.9K | 33,830 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-03-12 | 2026-03-13 | 23,465 | $81.75 | $1.92M | 4,365 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-03-12 | 2026-03-13 | 3,865 | $82.66 | $319.5K | 500 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-03-12 | 2026-03-13 | 200 | $83.38 | $16.7K | 300 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-03-12 | 2026-03-13 | 300 | $85.53 | $25.7K | 0 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | S Sale | 2026-03-12 | 2026-03-13 | 15,852 | $80.71 | $1.28M | 27,830 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-03-12 | 2026-03-13 | 16,182 | $17.88 | $289.3K | 16,182 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-03-12 | 2026-03-13 | 17,500 | $22.07 | $386.2K | 33,682 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-03-12 | 2026-03-13 | 10,000 | $21.77 | $217.7K | 43,682 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-03-12 | 2026-03-13 | 900 | $85.53 | $77.0K | 0 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-03-12 | 2026-03-13 | 200 | $83.38 | $16.7K | 900 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-03-12 | 2026-03-13 | 12,796 | $82.60 | $1.06M | 1,100 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | M Exercise | 2026-03-12 | 2026-03-13 | 122,918 | $6.70 | $823.6K | 122,918 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-03-12 | 2026-03-13 | 43,505 | $80.69 | $3.51M | 79,413 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | S Sale | 2026-03-12 | 2026-03-13 | 65,517 | $81.74 | $5.36M | 13,896 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | A Award deriv | 2026-02-03 | 2026-02-04 | 355,000 | — | $0 | 355,000 | SEC↗ |
| Savitz Ryan | EVP, CFO & CBO | A Award deriv | 2026-02-03 | 2026-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | A Award deriv | 2026-02-03 | 2026-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | A Award deriv | 2026-02-03 | 2026-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-02-03 | 2026-02-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | M Exercise deriv | 2025-12-04 | 2025-12-05 | 20,000 | — | $0 | 84,766 | SEC↗ |
| Savitz Ryan | CFO & CBO | M Exercise | 2025-12-04 | 2025-12-05 | 20,000 | $8.44 | $168.8K | 20,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | S Sale | 2025-12-04 | 2025-12-05 | 20,000 | $45.18 | $903.6K | 0 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2025-11-14 | 2025-11-14 | 31,250 | — | $0 | 118,750 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2025-11-14 | 2025-11-14 | 40,287 | — | $0 | 76,184 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2025-11-14 | 2025-11-14 | 37,494 | — | $0 | 62,506 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2025-11-14 | 2025-11-14 | 109,031 | $38.14 | $4.16M | 4,000 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2025-11-14 | 2025-11-14 | 31,250 | $22.07 | $689.7K | 113,031 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2025-11-14 | 2025-11-14 | 37,494 | $21.77 | $816.2K | 81,781 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2025-11-14 | 2025-11-14 | 40,287 | $17.88 | $720.3K | 44,287 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2025-11-13 | 2025-11-14 | 83,978 | — | $0 | 11,996 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise deriv | 2025-11-13 | 2025-11-14 | 3,529 | — | $0 | 116,471 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2025-11-13 | 2025-11-14 | 3,529 | $17.88 | $63.1K | 91,507 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | M Exercise | 2025-11-13 | 2025-11-14 | 83,978 | $8.44 | $708.8K | 87,978 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2025-11-13 | 2025-11-14 | 26,166 | $35.80 | $936.7K | 65,341 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2025-11-13 | 2025-11-14 | 42,765 | $37.04 | $1.58M | 22,576 | SEC↗ |
| Randhawa Simrat | EVP, Head of R&D | S Sale | 2025-11-13 | 2025-11-14 | 18,576 | $37.72 | $700.7K | 4,000 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | A Award deriv | 2025-09-30 | 2025-10-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Randhawa Simrat | CHIEF MEDICAL OFFICER | A Award deriv | 2025-09-23 | 2025-09-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | A Award deriv | 2025-09-23 | 2025-09-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | M Exercise deriv | 2025-09-09 | 2025-09-11 | 20,000 | — | $0 | 104,766 | SEC↗ |
| Savitz Ryan | CFO & CBO | M Exercise | 2025-09-09 | 2025-09-11 | 20,000 | $8.44 | $168.8K | 20,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | S Sale | 2025-09-09 | 2025-09-11 | 20,000 | $35.00 | $700.0K | 0 | SEC↗ |
| Read Simon | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Romano Steven J. | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Soteropoulos Paula | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KANGO SUJAY | Director | A Award deriv | 2025-03-04 | 2025-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | A Award deriv | 2025-02-03 | 2025-02-04 | 340,000 | — | $0 | 340,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | A Award deriv | 2025-02-03 | 2025-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Randhawa Simrat | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-03 | 2025-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | A Award deriv | 2025-02-03 | 2025-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | A Award deriv | 2025-02-03 | 2025-02-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Kiselak Tomas | Director | J Other | 2024-09-27 | 2024-10-01 | 62,146 | — | $0 | 0 | SEC↗ |
| Romano Steven J. | Director | A Award deriv | 2024-09-16 | 2024-09-18 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Fairmount Funds Management LLC | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MOULDER LEON O JR | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Soteropoulos Paula | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | A Award deriv | 2024-05-23 | 2024-05-28 | 243,000 | — | $0 | 243,000 | SEC↗ |
| Savitz Ryan | CFO & CBO | A Award deriv | 2024-05-23 | 2024-05-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Randhawa Simrat | CHIEF MEDICAL OFFICER | A Award deriv | 2024-05-23 | 2024-05-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | A Award deriv | 2024-05-23 | 2024-05-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | A Award deriv | 2024-05-23 | 2024-05-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | J Other | 2024-04-01 | 2024-04-01 | 58,857 | — | $0 | 0 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | J Other | 2024-04-01 | 2024-04-01 | 58,857 | — | $0 | 2,700,691 | SEC↗ |
| Garcia Marino | CEO AND PRESIDENT | A Award deriv | 2024-01-24 | 2024-01-26 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Savitz Ryan | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Randhawa Simrat | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Veness Adam M | SVP, General Counsel and Sec | A Award deriv | 2024-01-24 | 2024-01-26 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Avidity Partners Management (G | Director | A Award deriv | 2024-01-22 | 2024-01-24 | 1,833,333 | $12.00 | $22.00M | 1,833,333 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | A Award deriv | 2024-01-22 | 2024-01-24 | 832,333 | $12.00 | $9.99M | 832,333 | SEC↗ |
| Avidity Partners Management (G | Director | A Award | 2024-01-22 | 2024-01-24 | 1,500,000 | $12.00 | $18.00M | 2,717,554 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | A Award | 2024-01-22 | 2024-01-24 | 834,334 | $12.00 | $10.01M | 2,762,837 | SEC↗ |
| MOULDER LEON O JR | Director | A Award | 2024-01-22 | 2024-01-24 | 166,667 | $12.00 | $2.00M | 1,436,745 | SEC↗ |
| Harwin Peter Evan | Director, 10% Owner | P Buy | 2023-09-29 | 2023-10-03 | 24,670 | $13.63 | $336.3K | 1,928,503 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | P Buy | 2023-09-26 | 2023-09-28 | 30,000 | $13.15 | $394.5K | 1,903,833 | SEC↗ |
| Randhawa Simrat | Chief Medical Officer | P Buy | 2023-09-22 | 2023-09-25 | 2,000 | $13.20 | $26.4K | 4,000 | SEC↗ |
| Randhawa Simrat | Chief Medical Officer | P Buy | 2023-09-21 | 2023-09-25 | 2,000 | $13.20 | $26.4K | 2,000 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | P Buy | 2023-09-19 | 2023-09-21 | 30,000 | $13.20 | $396.0K | 1,873,833 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | P Buy | 2023-09-13 | 2023-09-13 | 9,367 | $11.76 | $110.2K | 1,843,833 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | P Buy | 2023-09-12 | 2023-09-13 | 14,887 | $10.85 | $161.5K | 1,834,466 | SEC↗ |
| MOULDER LEON O JR | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Soteropoulos Paula | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Kiselak Tomas | Director, 10% Owner | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Avidity Partners Management LP | Director | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |